In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

Hemifusomes are fused vesicles, or sacs of fluid, that were previously unknown to exist inside cells. They were discovered ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

The role of ApoE has been well-studied outside of the cell, but what happens after it’s let inside? Scientists led by Raimund Dutzler, University of Zurich, have identified Tweety homologue 2 as an ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

In a significant step towards improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for ...

A recent study reveals that slowing down the intracellular transport of RNA-based drugs can significantly enhance their effectiveness. These therapeutics are currently used to treat rare genetic ...

A breakthrough in cancer therapy: metal-phenolic nanocarriers deliver antibodies directly to cancer cells, improving treatment efficacy and reducing toxicity.